New Threads Only:  Add to Google Reader or Homepage
New Threads & Replies:  Add to Google Reader or Homepage
Forums are for serious investors only. GuruFocus Forum Rules.

Forum List » Guru News and Commentaries
Guru News, Stock picks and commentaries
New Topic Search
Goto Thread: PreviousNext
Goto: Forum ListMessage ListNew TopicSearchLog In
Delphi's Scott Black Discusses His Top Picks
Posted by: Dheeraj Grover (IP Logged)
Date: January 30, 2013 09:23AM

Well-know value investor and hedge fund manager Scott Black of Delphi Asset Management was at on CNBC to discuss his top picks.

-- Stocks are still cheap and good place to be despite his prediction of slower earnings growth.
-- Consumers are still not in good shape and it is the consumer which drives the economy.
-- Predicts market can go up 10% to 12% this year.
-- Debt ceiling debate will bring risk and can derail the rally.
-- Large cap stocks are much cheaper versus small and mid caps.
-- There is a big bubble in bonds.
-- His top picks:
-- In technology space - Cisco (CSCO), Apple (AAPL), Qualcomm (QCOM).
-- In health care - Medical Properties Trust (MPT), it has 6% yield, acute care hospitals, long-term acute care hospitals, solid dividend coverage and solid balance sheet.
-- McKeeson (MCK), EPS of $8.10, high 12 multiple, earnings growing at 10% per year, $1 billion of free cash flow, stock repurchases, benefiting from move from branded to generics.

Credit and source: www.cnbc.com, CNBC

Here is the video, disregard the first 5 minutes of video, Scott comes in at around 5:08 in the video







Guru Discussed: Scott Black: Current Portfolio, Stock Picks
Stocks Discussed: MPT, MCK, CSCO, AAPL, INTC,
Rate this post:

Rating: 5.0/5 (1 vote)





Sorry, only registered users may post in this forum.

Please Login if you have an account or Create a Free Account if you don't
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK